Prostate-Specific Antigen Trends Predict the Probability of Prostate Cancer in a Very Large U.S. Veterans Affairs Cohort

about

Prostate-Specific Antigen Trends Predict the Probability of Prostate Cancer in a Very Large U.S. Veterans Affairs Cohort

Item

http://www.wikidata.org/entity/Q58799069

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Prostate-Specific Antigen Tren ...... e U.S. Veterans Affairs Cohort

@en

Prostate-Specific Antigen Tren ...... e U.S. Veterans Affairs Cohort

@nl

type

Item

label

Prostate-Specific Antigen Tren ...... e U.S. Veterans Affairs Cohort

@en

Prostate-Specific Antigen Tren ...... e U.S. Veterans Affairs Cohort

@nl

prefLabel

Prostate-Specific Antigen Tren ...... e U.S. Veterans Affairs Cohort

@en

Prostate-Specific Antigen Tren ...... e U.S. Veterans Affairs Cohort

@nl

P1476

Prostate-Specific Antigen Tren ...... e U.S. Veterans Affairs Cohort

@en

P2093

Christopher H Morrell

http://www.w3.org/2001/XMLSchema#string

Lori Rawson

http://www.w3.org/2001/XMLSchema#string

Michele Colicchia

http://www.w3.org/2001/XMLSchema#string

Preston C Sprenkle

http://www.w3.org/2001/XMLSchema#string

R Jeffrey Karnes

http://www.w3.org/2001/XMLSchema#string

Thomas B Neville

http://www.w3.org/2001/XMLSchema#string

P2860

Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease

Comparison of MR/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer.

Distribution of PSA velocity by total PSA levels: data from the Baltimore Longitudinal Study of Aging.

Prostate-specific antigen velocity for early detection of prostate cancer: result from a large, representative, population-based cohort

Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up.

The relationship between prostate volume and prostate-specific antigen variability: data from the Baltimore Longitudinal Study of Aging and the Johns Hopkins Active Surveillance Program.

Interpretation of the prostate-specific antigen history in assessing life-threatening prostate cancer.

Prostate-cancer mortality at 11 years of follow-up.

Evaluation of prediagnostic prostate-specific antigen dynamics as predictors of death from prostate cancer in patients treated conservatively

The prostate health index selectively identifies clinically significant prostate cancer.

P304

296

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FONC.2018.00296

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

Michael W Kattan

Frederick Roy MacKintosh

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30128303

http://www.w3.org/2001/XMLSchema#string

P921

cancer research

P932

6088151

http://www.w3.org/2001/XMLSchema#string